Vice President, Early Oncology Clinical Development
Company: IDEAYA Biosciences
Location: South San Francisco
Posted on: October 30, 2025
|
|
|
Job Description:
Non-Solicitation Policy and Notice to Agencies and Recruiters:
IDEAYA's Non-Solicitation Policy strictly prohibits agencies and
recruiters from any contact and communication with IDEAYA
employees, managers, and leaders to submit unsolicited candidate
resumes and/or to solicit business partnerships . Submission of
unsolicited candidate resumes by agencies or recruiters with or
without a contract in place with IDEAYA Biosciences Inc. will not
create any implied obligation. Failure to comply with this policy
will result in disqualification from current and future business
opportunities with IDEAYA Biosciences. All recruiting and talent
agency decisions are strictly managed by the internal IDEAYA Human
Resources function. All communication by external agencies and
recruiters must be directed to humanresources@ideayabio.com. We ask
that you only email your interest once. Job Summary About IDEAYA
Biosciences: IDEAYA is a precision medicine oncology company
committed to the discovery, development, and commercialization of
transformative therapies for cancer. Our approach integrates
expertise in small-molecule drug discovery, structural biology and
bioinformatics with robust internal capabilities in identifying and
validating translational biomarkers to develop tailored,
potentially first-in-class targeted therapies aligned to the
genetic drivers of disease. We have built a deep pipeline of
product candidates focused on synthetic lethality and antibody-drug
conjugates, or ADCs, for molecularly defined solid tumor
indications. Our mission is to bring forth the next wave of
precision oncology therapies that are more selective, more
effective, and deeply personalized with the goal of altering the
course of disease and improving clinical outcomes for patients with
cancer. When you're at IDEAYA, you will be in the midst of
brilliant minds working on precision medicine therapies to help
cancer patients. We are passionate and committed about being on the
forefront of oncology medicine, which means we all have a high
internal drive that is at the very core of every person at IDEAYA.
We are inquisitive, ask deep questions, and are data-driven
innovators who like to collaborate and use team work to move
science forward. For more information, please see
www.ideayabio.com. Location: South San Francisco Position Summary:
We are seeking a Vice President of Early Oncology Clinical
Development to join our IDEAYA’s Clinical Development team. The
Vice President of Early Oncology Clinical Development is
responsible for providing medical direction, management, and review
of clinical trials and product development. Specific tasks include
oversight of the strategy and design of clinical development
programs for ongoing and new drug candidates, clinical protocol
development, medical monitoring of clinical trials (where needed),
and analysis of study data and preparation of trial reports and
related regulatory documents. The individual may also serve as
Development Project Leader for specific assets as the department
evolves and will interact with most functions to ensure the
successful progress of projects and clinical trials. This
individual will have a solid understanding of all phases of
clinical drug development including translational science and
operational excellence. Effective written and verbal communication
skills are required as is an ability to influence across functions
and levels, with flexibility/adaptability to work in a fast-paced
environment. This position is based in our South San Francisco
headquarters and is required to be onsite four days per week per
our company policy. This position reports to the Senior Vice
President, Clinical Development. Job Description What you’ll do:
Oversees all early oncology development program activities and is
responsible for execution of programs and timelines Applies disease
knowledge to clinical research trial development Drives protocol
development for clinical studies in collaboration with Clinical
Operations and other clinical sub-team functions Drives preparation
of clinical development plans in partnership with cross-functional
teams Works collaboratively with associated clinical functions to
oversee and participate in drafting clinical scientific documents
such as IND, IND amendments, Investigator Brochures, Annual Reports
(DSUR), and other FDA/HA submissions Contributes to CSR preparation
and finalization In association with clinical operations colleagues
and clinical scientists, contributes to the development of CRFs and
data review plans when needed Oversees the Monitoring and review of
safety and efficacy data in ongoing studies Serves as the key
decision maker for clinical questions associated with eligibility,
AE management, etc. for clinical studies Participates in developing
clinical abstracts, and/or presents data at scientific meetings,
SIVs, and conducts protocol training where needed Develop and
participate in advisory boards Keeps abreast of hematology/oncology
treatments, drug mechanism of action, approaches to drug
development and regulatory requirements Acts as a clinical
representative in variety of cross-functional and executive teams
Partners with Research, Translational/Biomarker and other
Preclinical teams to help guide advancement of drug candidates with
meaningful safety: efficacy profiles Serves as clinical partner for
Business Development Requirements: Medical degree and medical
oncology training required Minimum of ten years of clinical drug
development experience Industry experience required Thorough
understanding of oncology clinical trial design, including
first-in-human Phase 1 studies of small molecules Experience and
understanding of clinical trial data monitoring and all aspects of
drug development Knowledge of GCP and ICH guidelines Leadership and
Management experience highly desirable Personal Strengths: A proven
self-starter and team player with strong interpersonal skills who
establishes & nurtures highly effective relationships with
colleagues and key stakeholders to support and advance project
goals and objectives Critical thinker with a solutions-oriented
mindset Self-motivated to work effectively in a dynamic environment
Possess strong organizational skills and conflict resolution
abilities Deep experience and knowledge in oncology clinical
development Total Rewards Along with our inspiring mission, and
highly collaborative and inclusive environment, IDEAYA offers a
competitive total rewards package that reflects our
pay-for-performance philosophy where employees are eligible to be
considered for merit-based salary increases, company discretionary
short-term incentive plan participation, and company discretionary
stock option awards (based on board approval). Our comprehensive
benefits package includes, but is not limited to,
medical/dental/vision coverage (100% company paid for employees and
90% company paid for dependents), 401k, ESPP, and wellness
programs. The expected salary range for the roleof Vice President,
Early Oncology Clinical Development is $328,000 - $405,000. The
final salary offered to a successful candidate will depend on
several factors that may include but are not limited to the office
location where this open position is located, the final candidates’
experience within their profession, experience in the disease areas
we are striving to make an impact in as a company, length of time
within the industry, educational background, and performance during
the interview process. The Company complies with all laws
respecting equal employment opportunities and does not discriminate
against applicants with regard to any protected characteristic as
defined by federal, state, and local law. This position requires
you to work onsite in the office at the Company’s facilities for
training & meetings, with work-from-home flexibility, and the
Company requires that all employees working in its facilities be
fully vaccinated (except as required by applicable law). Therefore,
this position requires you to be fully vaccinated from COVID-19,
subject to reasonable accommodations for medical or religious
reasons, and/or as otherwise required by applicable law. The
Company considers you fully vaccinated once 14 days have passed
since you received either the second dose in a two-dose COVID-19
vaccine series or a single-dose COVID-19 vaccine. The vaccine must
have been FDA approved, have emergency use authorization from the
FDA, or, for persons fully vaccinated outside of the U.S., be
listed for emergency use by the World Health Organization. IDEAYA
is an equal opportunity employer. In accordance with applicable
law, IDEAYA does not discriminate in hiring or otherwise in
employment based on race, color, religion, sex, national origin,
age, marital or veteran status, disability, sexual orientation, or
any other legally protected status. EOE/AA/Vets.
Keywords: IDEAYA Biosciences, South San Francisco , Vice President, Early Oncology Clinical Development, Science, Research & Development , South San Francisco, California